The Role of the Microbiome in Driving RA-Related Autoimmunity

by Cristopher M. Rooney, Kulveer Mankia, Kulveer Mankia, Paul Emery, Paul Emery
Published 2020-09-01

The Role of Ultrasound Across the Inflammatory Arthritis Continuum: Focus on “At-Risk” Individuals

by Laurence Duquenne, Laurence Duquenne, Rahaymin Chowdhury, Kulveer Mankia, Kulveer Mankia, Paul Emery, Paul Emery
Published 2020-10-01

Recent advances in ankylosing spondylitis: understanding the disease and management [version 1; referees: 2 approved]

by Leticia Garcia-Montoya, Hanna Gul, Paul Emery
Published 2018-09-01

Efficacy, tolerability and safety of biologic therapy in rheumatoid disease: patient considerations

by Sarah Horton, Maya H Buch, Paul Emery
Published 2010-08-01

DNA Hypomethylation in the TNF-Alpha Gene Predicts Rheumatoid Arthritis Classification in Patients with Early Inflammatory Symptoms

by Rujiraporn Pitaksalee, Rekha Parmar, Richard Hodgett, Paul Emery, Frederique Ponchel
Published 2023-09-01

Experimental infection of Asian house geckos with Enterococcus lacertideformus demonstrates multiple disease transmission routes and the in-vivo efficacy of antibiotics

by Jessica E. Agius, Karrie Rose, Jon-Paul Emery, David N. Phalen
Published 2021-07-01

LDL cholesterolemia as a novel risk factor for radiographic progression of rheumatoid arthritis: a single-center prospective study.

by Yune-Jung Park, Chul-Soo Cho, Paul Emery, Wan-Uk Kim
Published 2013-01-01

The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis

by Yoshiya Tanaka, Josef S. Smolen, Heather Jones, Annette Szumski, Lisa Marshall, Paul Emery
Published 2019-07-01

The role of ultrasonography in rheumatology

by Kok Ooi Kong, Damien Loeuille, Yohei Seto, Richard J. Wakefield, Paul Emery
Published 2003-10-01

Biologic Sequencing in Systemic Lupus Erythematosus: After Secondary Non-response to Rituximab, Switching to Humanised Anti-CD20 Agent Is More Effective Than Belimumab

by Sabih Ul Hassan, Sabih Ul Hassan, Md Yuzaiful Md Yusof, Md Yuzaiful Md Yusof, Paul Emery, Paul Emery, Shouvik Dass, Shouvik Dass, Edward M. Vital, Edward M. Vital
Published 2020-08-01

Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data

by Paul Emery, Daniel E. Furst, Petra Kirchner, Simone Melega, Stuart Lacey, Patricia B. Lehane
Published 2019-11-01

Subcutaneous Sarilumab in Patients With Rheumatoid Arthritis who Previously Received Subcutaneous Sarilumab or Intravenous Tocilizumab: An Open‐Label Extension of a Randomized Clin...

by Paul Emery, Hubert vanHoogstraten, Karthinathan Thangavelu, Erin Mangan, Gregory St John, Patrick Verschueren
Published 2020-11-01

Predicting Flare in Patients With Rheumatoid Arthritis in Biologic Induced Remission, on Tapering, and on Stable Therapy

by Hanna Gul, Andrea Di Matteo, Innocent Anioke, Farag Shuweidhi, Kulveer Mankia, Frederique Ponchel, Paul Emery
Published 2024-05-01

A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis

by Jack Arnold, Edward M. Vital, Edward M. Vital, Shouvik Dass, Shouvik Dass, Aamir Aslam, Aamir Aslam, Andy C. Rawstron, Sinisa Savic, Sinisa Savic, Paul Emery, Paul Emery, Md Yuzaiful Md Yusof, Md Yuzaiful Md Yusof
Published 2022-01-01

Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis

by Paul Emery, Yoshiya Tanaka, Tracy Cardillo, Douglas Schlichting, Terence Rooney, Scott Beattie, Cameron Helt, Josef S. Smolen
Published 2020-05-01

Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis

by Paul Emery, Yoshiya Tanaka, Tracy Cardillo, Douglas Schlichting, Terence Rooney, Scott Beattie, Cameron Helt, Josef S. Smolen
Published 2020-07-01

Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals

by Paul Emery, K Mankia, Laurence Duquenne, Farag Shuweihdi, L A Trouw, Frederique Ponchel, Diane Corscadden, Xuanxiao Xie
Published 2022-12-01

Baricitinib inhibits structural joint damage progression in patients with rheumatoid arthritis—a comprehensive review

by Paul Emery, Patrick Durez, Axel J. Hueber, Inmaculada de la Torre, Esbjörn Larsson, Thorsten Holzkämper, Yoshiya Tanaka
Published 2021-01-01

IL-6 Mediated Transcriptional Programming of Naïve CD4+ T Cells in Early Rheumatoid Arthritis Drives Dysregulated Effector Function

by Laura A. Ridgley, Amy E. Anderson, Nicola J. Maney, Najib Naamane, Andrew J. Skelton, Catherine A. Lawson, Catherine A. Lawson, Paul Emery, Paul Emery, John D. Isaacs, John D. Isaacs, Ruaidhrí J. Carmody, Arthur G. Pratt, Arthur G. Pratt
Published 2019-07-01

Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative sec...

by Kulveer Mankia, Paul Emery, Michael Mahler, Andrea Di Matteo, Laurence Duquenne, Leticia Garcia-Montoya, Jacqueline L Nam, Sana Sharrack
Published 2024-05-01